SANGAMO THERAPEUTICS, INC (SGMO) has 100 open-market insider trades by 25 insiders since 2000. Over the last six months insiders net sold $107K. The most active filer is Kathy Yi, CFO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RA Capital Healthcare Fund LP | — | — | 4 | $84.4M | 2014-08-01 |
| Peter Kolchinsky | — | — | 3 | $43.7M | 2014-05-07 |
| Biogen Inc. | 10% Owner | — | 6 | $9.7M | 2023-09-26 |
| LeRoy C. Kopp | 10% | — | 3 | $8.0M | 2007-05-21 |
| Curt A. Herberts III | VP | — | 10 | $2.3M | 2018-04-13 |
| Edward R. Conner | VP | — | 14 | $1.1M | 2019-01-24 |
| Steven J. Mento | Dir | — | 5 | $1.1M | 2018-06-11 |
| Kathy Yi | CFOVP | — | 15 | $1.0M | 2019-05-15 |
| Edward O. Lanphier II | Dir | — | 2 | $975K | 2016-06-13 |
| William R. Ringo | Dir | — | 3 | $930K | 2017-09-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Gregory D. Davis | — | Sell | $18K | 2026-04-22 |
| Nathalie Dubois-Stringfellow | VP | Sell | $89K | 2026-04-21 |
| Biogen Inc. | 10% Owner | Sell | $3.0M | 2023-09-26 |
| Biogen Inc. | 10% Owner | Sell | $2.7M | 2022-08-29 |
| John Markels | Director | Buy | $25K | 2022-06-03 |
| H. Stewart Parker | Director | Buy | $18K | 2022-06-01 |
Companies that share insiders with SGMO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Biogen Inc. | 10% | Sell | $24K | 2021-12-28 |
| Biogen Inc. | 10% Owner | Sell | $1.4M | 2021-12-23 |
| Biogen Inc. | 10% Owner | Sell | $405K | 2021-12-09 |
| Biogen Inc. | 10% Owner | Sell | $2.2M | 2021-12-07 |
| Biogen MA Inc. | 10% | Sell | $22K | 2021-12-01 |
| Biogen MA Inc. | 10% Owner | Sell | $497K | 2021-11-26 |
| Gary Loeb | CLO & VP +1 | Sell | $387K | 2021-03-23 |
| Rolf Andrew Ramelmeier | EVP & Technical Operations | Sell | $41K | 2020-12-31 |
| Rolf Andrew Ramelmeier | VP | Sell | $121K | 2020-12-24 |